Hims House podcast

Why payment processors treat peptides as "riskier than gambling", per gray-market peptide CEO

20/10/2026
0:00
55:35
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Thanks to our partners:

Superpower - https://superpower.com

CareValidate - https://carevalidate.com


FDA warning letter: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peptide-partners-llc-735063-08242026


In episode 84, Jonathan Stern talks with Zak David, founder of Peptide Partners, one of the largest research-peptide sellers in the US. This is Zak's first and only interview discussing Peptide Partners' FDA warning letter! We get into why payment processors consider research peptides riskier than gambling, what advice he'd give Hims, and whether the gray market will be even bigger in three years. Zak also responds to Martin Shkreli's claim that peptides are setting Western medicine back 70 years.


00:00 - Sponsors: Superpower + CareValidate

01:49 - How Zak found peptides

04:19 - 80% of vials now "fill-finished" in the US

06:15 - Just under 100K customers all-time

08:48 - Retatrutide is #1

12:33 - Zak's take on the FDA letter

20:25 - Peptides "riskier than gambling" to payment processors

25:01 - Why they now test more than 10 vials per batch

31:06 - All China today, India lab coming in December

31:04 - Peptide Partners' supply chain today

34:58 - American-made peptide potential pricing

40:48 - Grindr's $250 million deal

46:32 - TSA agent recognized his peptide vials

49:48 - Zak's advice to Hims & Andrew Dudum

52:22 - Why Shkreli is wrong about peptides


Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions.

Altri episodi di "Hims House"